199 related articles for article (PubMed ID: 34375673)
1. Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells.
Takiguchi T; Takahashi-Yanaga F; Ishikane S; Tetsuo F; Hosoda H; Arioka M; Kitazono T; Sasaguri T
Eur J Pharmacol; 2021 Oct; 909():174415. PubMed ID: 34375673
[TBL] [Abstract][Full Text] [Related]
2. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
3. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer.
Li C; Yoshimura T; Tian M; Wang Y; Kondo T; Yamamoto KI; Fujisawa M; Ohara T; Sakaguchi M; Matsukawa A
Breast Cancer Res; 2022 Sep; 24(1):60. PubMed ID: 36096830
[TBL] [Abstract][Full Text] [Related]
4. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
5. TLR5: A prognostic and monitoring indicator for triple-negative breast cancer.
Shi D; Zhao S; Jiang W; Zhang C; Liang T; Hou G
Cell Death Dis; 2019 Dec; 10(12):954. PubMed ID: 31852883
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer.
Imamura M; Li T; Li C; Fujisawa M; Mukaida N; Matsukawa A; Yoshimura T
Curr Issues Mol Biol; 2021 Oct; 43(3):1726-1740. PubMed ID: 34698088
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis.
Sasaki S; Baba T; Nishimura T; Hayakawa Y; Hashimoto S; Gotoh N; Mukaida N
Cancer Lett; 2016 Aug; 378(1):23-32. PubMed ID: 27177471
[TBL] [Abstract][Full Text] [Related]
8. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide deficiency and endothelial-mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice.
Smeda M; Kieronska A; Adamski MG; Proniewski B; Sternak M; Mohaissen T; Przyborowski K; Derszniak K; Kaczor D; Stojak M; Buczek E; Jasztal A; Wietrzyk J; Chlopicki S
Breast Cancer Res; 2018 Aug; 20(1):86. PubMed ID: 30075800
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.
Liu Z; Zhang B; Liu K; Ding Z; Hu X
PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model.
Cho HJ; Jung JI; Lim DY; Kwon GT; Her S; Park JH; Park JH
Breast Cancer Res; 2012 May; 14(3):R81. PubMed ID: 22616919
[TBL] [Abstract][Full Text] [Related]
13. In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells.
Ke CC; Liu RS; Suetsugu A; Kimura H; Ho JH; Lee OK; Hoffman RM
PLoS One; 2013; 8(7):e69658. PubMed ID: 23936067
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
[TBL] [Abstract][Full Text] [Related]
15. Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion.
Richardson AM; Havel LS; Koyen AE; Konen JM; Shupe J; Wiles WG; Martin WD; Grossniklaus HE; Sica G; Gilbert-Ross M; Marcus AI
Clin Cancer Res; 2018 Jan; 24(2):420-432. PubMed ID: 29208669
[No Abstract] [Full Text] [Related]
16. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells.
Ishikane S; Hosoda H; Nojiri T; Tokudome T; Mizutani T; Miura K; Akitake Y; Kimura T; Imamichi Y; Kawabe S; Toyohira Y; Yanagihara N; Takahashi-Yanaga F; Miyazato M; Miyamoto K; Kangawa K
Biochem Pharmacol; 2018 Aug; 154():136-147. PubMed ID: 29674000
[TBL] [Abstract][Full Text] [Related]
18. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
19. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]